This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genentech, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Jian Ping Yin
Introduction
Jian Ping Yin is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on addressing TGFβ-related disorders, which are critical in various medical conditions.
Latest Patents
Jian Ping Yin holds a patent for "Isoform-selective anti-TGFβ antibodies and methods of use." This invention provides isoform-selective anti-TGFβ antibodies, specifically targeting anti-TGFβ2, anti-TGFβ3, and anti-TGFβ2/3 monoclonal antibodies. These antibodies are designed for the treatment of fibrosis and other disorders related to TGFβ, showcasing his innovative approach to medical therapies.
Career Highlights
Yin is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing medicines for serious medical conditions. His role at Genentech allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Wei-Ching Liang and Joseph R Arron. Their collaboration enhances the research environment, fostering innovation and the development of new therapeutic solutions.
Conclusion
Jian Ping Yin's contributions to the field of biotechnology through his patent and work at Genentech highlight his role as an influential inventor. His focus on isoform-selective anti-TGFβ antibodies represents a significant advancement in the treatment of TGFβ-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile